Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002040052 | SCV002108710 | uncertain significance | Hereditary spastic paraplegia 48 | 2022-03-28 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 397 of the AP5Z1 protein (p.Pro397Leu). This variant is present in population databases (rs759329689, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of AP5Z1-related conditions (PMID: 31785789). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Breakthrough Genomics, |
RCV004693795 | SCV005188414 | uncertain significance | not provided | criteria provided, single submitter | not provided |